Quoin Pharmaceuticals Ltd.
Dr. Michael Myers – Chief Executive Officer
Dr. Myers has more than 30 years of industry experience in the drug delivery and specialty pharmaceutical sectors.
Dr. Michael Myers has served CEO of Innocoll, Inc. and was responsible for taking that company public in 2014. He has also served as president of the drug delivery division of West Pharmaceutical Services, president of pharmaceutical operations for Fuisz Technologies (Biovail) and has held executive positions in Flamel Technologies and Elan Corporation. Dr. Myers earned his Ph.D. in Chemistry from the University College Cork. Dr. Myers serves on the Board of Directors of Wellesley Pharmaceuticals, Venkor Pharmaceuticals and Sonoran Biosciences.
Denise Carter – Chief Operating Officer
Ms. Denise Carter has over 27 years of experience in the drug delivery and specialty pharmaceutical industries. Prior to Quoin, Ms. Carter was executive vice president of business development and corporate affairs at Innocoll, Inc., vice president of business development of the drug delivery division of West Pharmaceuticals, and she has held executive positions at Eurand and Fuisz Technologies (Biovail.) Ms. Carter earned her B.S in Chemistry from the College of William and Mary.
Stephen DiPalma Acting CFO
Managing Director Danforth Advisors
Steve has more than 30 years of experience in life sciences and healthcare, including founding two start-ups and working with venture-backed companies, subsidiaries of Fortune 100 firms and publicly traded companies. He previously served as CFO of two public companies and as CFO, COO, CEO or Director of eight privately held companies, in addition to his consulting clients. He has managed finance, accounting, corporate communications, human resources, information technology, facilities, business development, and manufacturing functions. Steve participated in the successful reorganization of Cambridge Biotech from Chapter 11 bankruptcy protection into Aquila BioPharmaceuticals, led the effort to take RXi public, and has extensive experience in international fundraising and corporate structuring. He was formerly Chairman of Cognoptix and is on the Board of Phytera, Inc. Steve’s core expertise includes operational management, strategic planning and corporate and business development, fundraising and mergers and acquisitions. He holds a BS from the University of Massachusetts and MBA from Babson College.